{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:09:17Z","timestamp":1775574557562,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Paraneoplastic pemphigus (PNP) is a rare autoimmune disorder associated with underlying neoplasms, predominantly Non-Hodgkin Lymphomas, affecting adults aged 45 to 70. This review analyzed 87 articles from MEDLINE\/PubMed, Ovid and Scopus focusing on patients with oral manifestations of PNP, emphasizing histological and serological aspects and discussing recent updates on pathogenetic options. Key findings revealed that PNP is often diagnosed before the neoplasm, with Follicular variant Non-Hodgkin Lymphoma and Castleman Disease being the most common associations. Histopathological analysis showed suprabasal acantholysis and inflammation, and serological tests identify a comprehensive autoantibody panel, underscoring the need for standardized diagnostic criteria and improved serological testing.<\/jats:p>","DOI":"10.3390\/antib13040095","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T07:54:20Z","timestamp":1732262060000},"page":"95","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral Paraneoplastic Pemphigus: A Scoping Review on Pathogenetic Mechanisms and Histo-Serological Profile"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-0800","authenticated-orcid":false,"given":"Domenico","family":"De Falco","sequence":"first","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4944-415X","authenticated-orcid":false,"given":"Sabrina","family":"Messina","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-3739","authenticated-orcid":false,"given":"Massimo","family":"Petruzzi","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e14353","DOI":"10.1111\/dth.14353","article-title":"Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience","volume":"33","author":"Wang","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/09273948.2016.1203958","article-title":"Ocular Onset of Paraneoplastic Pemphigus Presenting as Hyperemic Conjunctivitis and Massive Bilateral Eyelid Ulceration: A Case Report and Literature Review","volume":"26","author":"Piscopo","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29630151","DOI":"10.5070\/D3242038110","article-title":"Paraneoplastic pemphigus without antibodies to desmoglein 1 and 3","volume":"24","author":"Flood","year":"2018","journal-title":"Dermatol. Online J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Messina, S., De Falco, D., and Petruzzi, M. (2024). Oral Manifestations in Paraneoplastic Syndromes: A Systematic Review and Meta-Analysis. Oral Dis., 39415566.","DOI":"10.1111\/odi.15158"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Paolino, G., Didona, D., Magliulo, G., Iannella, G., Didona, B., Mercuri, S., Moliterni, E., Donati, M., Ciofalo, A., and Granata, G. (2017). Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122532"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/1756-185X.13407","article-title":"Masked pemphigus among pediatric patients with Castleman\u2019s disease","volume":"22","author":"Han","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_8","unstructured":"Kappius, R.H., Ufkes, N.A., and Thiers, B.H. (2024). Paraneoplastic Pemphigus. StatPearls, StatPearls Publishing."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/jocs.14955","article-title":"Paraneoplastic pemphigus associated with a pericardial ectopic thymoma","volume":"35","author":"Khurana","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1111\/jdv.14992","article-title":"Chronic oral lichenoid erosions revealing haematological malignancies","volume":"32","author":"Ouedraogo","year":"2018","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaad.2023.08.084","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management","volume":"91","author":"Huang","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1601-0825.2000.tb00115.x","article-title":"Paraneoplastic pemphigus: A review of the literature","volume":"6","author":"Allen","year":"2000","journal-title":"Oral Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/ijd.14056","article-title":"Paraneoplastic pemphigus in Russian patients: A single center case series","volume":"57","author":"Allenova","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","article-title":"Paraneoplastic pemphigus: Paraneoplastic pemphigus","volume":"54","author":"Yong","year":"2013","journal-title":"Australas. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40257-016-0235-z","article-title":"Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment","volume":"18","author":"Kartan","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/cup.14004","article-title":"Paraneoplastic pemphigus: Revised diagnostic criteria based on literature analysis","volume":"48","author":"Svoboda","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dsi.2013.04.006","article-title":"Paraneoplastic pemphigus: A retrospective case series in a referral center in northern Taiwan","volume":"32","author":"Cho","year":"2014","journal-title":"Dermatol. Sin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0190-9622(92)70220-A","article-title":"Paraneoplastic pemphigus: A report of three cases including one long-term survivor","volume":"27","author":"Camisa","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3892\/etm.2021.10770","article-title":"Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review)","volume":"22","author":"Costan","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/1346-8138.15289","article-title":"Paraneoplastic pemphigus associated with Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"47","author":"Shirai","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/bjd.14877","article-title":"Paraneoplastic pemphigus with anti-BP180 autoantibodies and Castleman disease","volume":"176","author":"Maier","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Van Beek, N., Holtsche, M.M., Atefi, I., Olbrich, H., Schmitz, M.J., Pruessmann, J., Vorobyev, A., and Schmidt, E. (2024). State-of-the-art diagnosis of autoimmune blistering diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1363032"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/odi.12527","article-title":"Desmosomes in disease: A guide for clinicians","volume":"23","author":"Celentano","year":"2017","journal-title":"Oral Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kim, J.H., and Kim, S.-C. (2019). Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01259"},{"key":"ref_27","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.1999.03123.x","article-title":"Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus","volume":"141","author":"Reich","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/bjd.17577","article-title":"Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies","volume":"180","author":"Kwatra","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaad.2006.06.007","article-title":"Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies","volume":"56","author":"Cummins","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/curroncol29040194","article-title":"Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes","volume":"29","author":"Gambichler","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00277-017-3171-y","article-title":"Paraneoplastic pemphigus without detectable anti-plakin antibodies in a patient with non-Hodgkin lymphoma","volume":"97","author":"Idoate","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/0378-6323.136898","article-title":"Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) with unusual manifestations and without detectable autoantibodies","volume":"80","author":"Cullen","year":"2014","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/ced.13563","article-title":"Lichenoid paraneoplastic pemphigus associated with follicular lymphoma without detectable autoantibodies","volume":"43","author":"Lim","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e229163","DOI":"10.1136\/bcr-2018-229163","article-title":"Thymoma-associated multiorgan autoimmunity","volume":"12","author":"Hung","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_36","first-page":"689","article-title":"Paraneoplastic pemphigus characterized by polymorphic oral mucosal manifestations\u2014Report of two cases","volume":"41","author":"Yan","year":"2010","journal-title":"Quintessence Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jormas.2018.06.003","article-title":"Buccal paraneoplastic pemphigus multi-resistant: Case report and review of diagnostic and therapeutic strategies","volume":"119","author":"Decaux","year":"2018","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"bcr2012007771","DOI":"10.1136\/bcr-2012-007771","article-title":"Paraneoplastic pemphigus presenting with a single oral lesion","volume":"2013","author":"Gissi","year":"2013","journal-title":"BMJ Case Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0560.2008.00993.x","article-title":"Paraneoplastic pemphigus with negative direct immunofluorescence in epidermis or mucosa but positive findings in adnexal structures","volume":"36","author":"Barnadas","year":"2009","journal-title":"J. Cutan. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/13\/4\/95\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:37:17Z","timestamp":1760114237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/13\/4\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antib13040095"],"URL":"https:\/\/doi.org\/10.3390\/antib13040095","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}